[ad_1] In a real-world badysis involving more than 11,000 patients with atrial fibrillation from 47 countries, the risk of stroke and major bleeding in users of the direct oral anticoagulant Xarelto (rivaroxaban …
Read More »Stroke Xarelto data in the real world reveals a risk of weak hemorrhage
